Article
US NIH launches long-COVID trials of Pfizer's Paxlovid, other therapies
Rating:
0.0
Views:
66
Likes:
1
Library:
1
The U.S. National Institutes of Health (NIH) said on Monday that it had launched mid-stage clinical trials to test at least four treatments, including Pfizer's Paxlovid, in patients with symptoms of long COVID.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value